Our estimated, unaudited revenue for the year ended December 31, 2020, was approximately $4.9 million compared to $5.5 for the year ended December 31, 2019, primarily due to the impact of COVID-19 on our businesses. WTF!!
3x the patient numbers?????
I think the cap Raising is 20M
- Forums
- ASX - By Stock
- GMV
- GMVD - NASDAQ IPO
GMVD - NASDAQ IPO, page-1174
-
- There are more pages in this discussion • 758 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online